|
GOLT1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45799999745822E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02660000003796E-07 |
| Normal-vs-Stage2 |
1.44739999996535E-06 |
| Normal-vs-Stage3 |
6.59140000358605E-08 |
| Normal-vs-Stage4 |
5.64820001880406E-09 |
| Stage1-vs-Stage2 |
3.133000E-01 |
| Stage1-vs-Stage3 |
2.439800E-01 |
| Stage1-vs-Stage4 |
2.458300E-02 |
| Stage2-vs-Stage3 |
8.971200E-01 |
| Stage2-vs-Stage4 |
3.396200E-01 |
| Stage3-vs-Stage4 |
2.191000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45890000080584E-08 |
| Normal-vs-AfricanAmerican |
7.817400E-04 |
| Normal-vs-Asian |
8.60039999994733E-07 |
| Caucasian-vs-AfricanAmerican |
7.340200E-01 |
| Caucasian-vs-Asian |
8.694000E-01 |
| AfricanAmerican-vs-Asian |
6.482400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00889999687936E-08 |
| Normal-vs-Female |
2.19500000397943E-08 |
| Male-vs-Female |
2.051200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.94000000003558E-06 |
| Normal-vs-Age(41-60Yrs) |
6.73760003344626E-09 |
| Normal-vs-Age(61-80Yrs) |
4.19080004032679E-09 |
| Normal-vs-Age(81-100Yrs) |
5.350200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.795600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.599800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.872400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.366800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.852400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.704200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.668600E-01 |
| Classical-VS-Follicular |
8.387600E-02 |
| Classical-VS-Other |
6.403000E-01 |
| Classical-VS-Normal |
9.26830000524959E-08 |
| Tall-VS-Follicular |
5.623000E-01 |
| Tall-VS-Other |
8.389800E-01 |
| Tall-VS-Normal |
2.150300E-04 |
| Follicular-VS-Other |
9.185400E-01 |
| Follicular-VS-Normal |
1.91629999979348E-07 |
| Other-VS-Normal |
1.886030E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.56919971145464E-10 |
| Normal-vs-N1 |
5.20750000010395E-07 |
| N0-vs-N1 |
8.457200E-01 |
|
|
